Heron Therapeutics Cash on Hand 2012-2025 | HRTX

Heron Therapeutics cash on hand from 2012 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Heron Therapeutics Annual Cash on Hand
(Millions of US $)
2024 $59
2023 $80
2022 $85
2021 $158
2020 $208
2019 $391
2018 $332
2017 $172
2016 $51
2015 $131
2014 $73
2013 $72
2012 $54
2011 $18
Heron Therapeutics Quarterly Cash on Hand
(Millions of US $)
2025-09-30 $55
2025-06-30 $41
2025-03-31 $51
2024-12-31 $59
2024-09-30 $71
2024-06-30 $67
2024-03-31 $72
2023-12-31 $80
2023-09-30 $77
2023-06-30 $33
2023-03-31 $60
2022-12-31 $85
2022-09-30 $122
2022-06-30 $84
2022-03-31 $112
2021-12-31 $158
2021-09-30 $203
2021-06-30 $258
2021-03-31 $166
2020-12-31 $208
2020-09-30 $258
2020-06-30 $301
2020-03-31 $356
2019-12-31 $391
2019-09-30 $256
2019-06-30 $276
2019-03-31 $289
2018-12-31 $332
2018-09-30 $365
2018-06-30 $423
2018-03-31 $114
2017-12-31 $172
2017-09-30 $74
2017-06-30 $109
2017-03-31 $165
2016-12-31 $51
2016-09-30 $89
2016-06-30 $75
2016-03-31 $100
2015-12-31 $131
2015-09-30 $153
2015-06-30 $172
2015-03-31 $56
2014-12-31 $73
2014-09-30 $86
2014-06-30 $105
2014-03-31 $57
2013-12-31 $72
2013-09-30 $23
2013-06-30 $35
2013-03-31 $46
2012-12-31 $54
2012-09-30 $60
2012-06-30 $12
2012-03-31 $13
2011-12-31 $18
2011-09-30 $21
2011-06-30 $21
2011-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.231B $0.144B
Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $92.346B 32.25
Takeda Pharmaceutical (TAK) Japan $56.926B 11.18
Zoetis (ZTS) United States $56.153B 20.10
BeOne Medicines - (ONC) Switzerland $38.812B 205.77
Sandoz Group AG (SDZNY) Switzerland $35.065B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.401B 0.00
United Therapeutics (UTHR) United States $20.898B 18.39
Merck (MKKGY) Germany $18.714B 11.54
Shionogi (SGIOY) Japan $18.571B 14.36
Neurocrine Biosciences (NBIX) United States $14.078B 33.78
Ionis Pharmaceuticals (IONS) United States $14.011B 0.00
IPSEN (IPSEY) France $13.491B 0.00
Summit Therapeutics (SMMT) United States $11.560B 0.00
Orion OYJ (ORINY) Finland $11.502B 32.86
Madrigal Pharmaceuticals (MDGL) United States $10.847B 0.00
Eisai (ESAIY) $8.574B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.149B 17.10
Stevanato Group S.p.A (STVN) Italy $4.694B 26.27
Crinetics Pharmaceuticals (CRNX) United States $4.626B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.591B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.565B 21.67
Indivior Pharmaceuticals (INDV) United States $4.296B 17.53
Corcept Therapeutics (CORT) United States $4.295B 46.40
NewAmsterdam Pharma (NAMS) Netherlands $3.889B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.158B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.004B 9.58
Hypermarcas (HYPMY) Brazil $2.755B 18.91
Dyne Therapeutics (DYN) United States $2.399B 0.00
Soleno Therapeutics (SLNO) United States $2.231B 0.00
Guardian Pharmacy Services (GRDN) United States $2.145B 41.32
Avadel Pharmaceuticals (AVDL) Ireland $2.118B 0.00
Ocular Therapeutix (OCUL) United States $1.994B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.904B 22.56
Ardelyx (ARDX) United States $1.779B 0.00
Harrow (HROW) United States $1.753B 107.54
Enliven Therapeutics (ELVN) United States $1.746B 0.00
Definium Therapeutics (DFTX) United States $1.665B 0.00
Oruka Therapeutics (ORKA) United States $1.600B 0.00
Relay Therapeutics (RLAY) United States $1.546B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.535B 0.00
Collegium Pharmaceutical (COLL) United States $1.505B 7.45
BioCryst Pharmaceuticals (BCRX) United States $1.345B 79.75
Evotec AG (EVO) Germany $1.254B 0.00
Xeris Biopharma Holdings (XERS) United States $1.163B 0.00
Savara (SVRA) United States $1.078B 0.00
Theravance Biopharma (TBPH) United States $1.038B 43.57
Cronos Group (CRON) Canada $1.004B 0.00
ARS Pharmaceuticals (SPRY) United States $0.991B 0.00
Aktis Oncology (AKTS) United States $0.961B 0.00
Xencor (XNCR) United States $0.829B 0.00
Esperion Therapeutics (ESPR) United States $0.813B 0.00
KalVista Pharmaceuticals (KALV) United States $0.753B 0.00
Nektar Therapeutics (NKTR) United States $0.749B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.742B 17.54
Bioventus (BVS) United States $0.704B 14.42
Rigel Pharmaceuticals (RIGL) United States $0.620B 5.53
ProKidney (PROK) United States $0.563B 0.00
Altimmune (ALT) United States $0.550B 0.00
Lexeo Therapeutics (LXEO) United States $0.523B 0.00
4D Molecular Therapeutics (FDMT) United States $0.514B 0.00
Aquestive Therapeutics (AQST) United States $0.501B 0.00
Zevra Therapeutics (ZVRA) United States $0.484B 0.00
Lyell Immunopharma (LYEL) United States $0.482B 0.00
Elite Pharmaceuticals (ELTP) United States $0.481B 0.00
Siga Technologies (SIGA) United States $0.480B 6.57
Organogenesis (ORGO) United States $0.478B 0.00
Nature's Sunshine Products (NATR) United States $0.461B 27.43
USANA Health Sciences (USNA) United States $0.390B 10.89
Aclaris Therapeutics (ACRS) United States $0.387B 0.00
Akebia Therapeutics (AKBA) United States $0.369B 0.00
Protara Therapeutics (TARA) United States $0.343B 0.00
Aldeyra Therapeutics (ALDX) United States $0.333B 0.00
Cybin (HELP) Canada $0.298B 0.00
Relmada Therapeutics (RLMD) United States $0.285B 0.00
Larimar Therapeutics (LRMR) United States $0.279B 0.00
Journey Medical (DERM) United States $0.278B 0.00
Enlivex Therapeutics (ENLV) Israel $0.275B 0.00
Avalo Therapeutics (AVTX) United States $0.263B 0.00
OmniAb (OABI) United States $0.245B 0.00
Profound Medical (PROF) Canada $0.236B 0.00
MediWound (MDWD) Israel $0.228B 0.00
Achieve Life Sciences (ACHV) Canada $0.226B 0.00
Silence Therapeutics (SLN) United Kingdom $0.224B 0.00
Context Therapeutics (CNTX) United States $0.209B 0.00
Minerva Neurosciences (NERV) United States $0.208B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Surrozen (SRZN) United States $0.195B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.181B 0.00
AleAnna (ANNA) United States $0.179B 0.00
Century Therapeutics (IPSC) United States $0.149B 0.00
VAXART, INC (VXRT) United States $0.146B 0.00
Unicycive Therapeutics (UNCY) United States $0.144B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.137B 0.00
Prelude Therapeutics (PRLD) United States $0.136B 0.00
Inhibikase Therapeutics (IKT) United States $0.128B 0.00
Avita Medical (RCEL) United States $0.119B 0.00
Korro Bio (KRRO) United States $0.118B 0.00
Karyopharm Therapeutics (KPTI) United States $0.115B 0.00
Cardiol Therapeutics (CRDL) Canada $0.111B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.110B 0.00
Incannex Healthcare (IXHL) Australia $0.100B 0.00
Vivani Medical (VANI) United States $0.098B 0.00
Cassava Sciences (SAVA) United States $0.098B 0.00
Pyxis Oncology (PYXS) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.091B 38.53
Assertio Holdings (ASRT) United States $0.082B 0.00
PolyPid (PYPD) Israel $0.072B 0.00
HST Global (HSTC) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.067B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
Dominari Holdings (DOMH) United States $0.061B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 48.88
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Fractyl Health (GUTS) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
BioNxt Solutions (BNXTF) Canada $0.056B 0.00
PMV Pharmaceuticals (PMVP) United States $0.055B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Acrivon Therapeutics (ACRV) United States $0.053B 0.00
Liminatus Pharma (LIMN) United States $0.050B 0.00
Lipocine (LPCN) United States $0.047B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
Telomir Pharmaceuticals (TELO) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Plus Therapeutics (PSTV) United States $0.036B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
Wellgistics Health (WGRX) United States $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.028B 0.00
TherapeuticsMD (TXMD) United States $0.027B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Klotho Neurosciences (KLTO) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
Iterum Therapeutics (ITRM) Ireland $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.02
Vyome Holdings (HIND) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
Inotiv (NOTV) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
BioVie (BIVI) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Lyra Therapeutics (LYRA) United States $0.003B 0.00
Ernexa Therapeutics (ERNA) United States $0.003B 0.00
China SXT Pharmaceuticals (SXTC) China $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00